NA
Nanobiotix
🇺🇸XNAS.NBTXUnited StatesHealthcare
$41.09USDup +1.08 (+2.7%)ClosedEnd of day3:07 AM
Price$41.09+1.08 (+2.7%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US63009J1079
- CUSIP
- Not reported
Company
- Employees
- 100
- Headquarters
- Paris, United States
- Website
- https://www.nanobiotix.com
- CEO
- Dr. Laurent Levy Ph.D.
Market
- Shares outstanding
- 50.8M
- Market cap
- $1.99B
Key dates
- Next earnings
- Sep 29, 2026
Highlights
- Market cap
- $1.99B
- EPS LTM
- -€0.50
- P/E LTM
- -39.40
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €29.64M
- Net income
- -€23.96M
- Gross margin
- Not reported
- Free cash flow
- -€33.97M
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.